MagnaPharm Baltics UAB Finance - turnover, revenue, profit
Financial ratios
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 814,264 |
| 183,393 |
| -241,519 |
| -241,519 |
| -54,396 |
| 56.50 |
| -29.66 |
| -262,134 |
| 519,499 |
| 26,966 |
| 313,524 |
| 2024 |
|---|
| 4,648,026 |
| 690,643 |
| 12,732 |
| -24,488 |
| -3,639 |
| 30.04 |
| -0.53 |
| 713,378 |
| 1,874,998 |
| 230,151 |
| 2,572,721 |
| 2025 |
|---|
| 6,500,920 |
| 725,549 |
| 2,691 |
| 2,691 |
| 300 |
| 30.27 |
| 0.04 |
| 716,069 |
| 1,752,848 |
| 437,667 |
| 2,150,173 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 6,500,920 |
| 725,549 |
| 2,691 |
| 2,691 |
| 300 |
| 30.27 |
| 0.04 |
| 716,069 |
| 1,752,848 |
| 437,667 |
| 2,150,173 |
Enjoy unlimited use
with Freemium unlimited2025
Turnover (€)
6,500,920 €40 % *
Sales per employee (€)
725,549 €5 % *
Profit before tax (€)
2,691 €-79 % *
Net Profit (€)
2,691 €111 % *
Profit per employee (€)
300 €108 % *
Total profitability (%)
30.27 %0.77 % *
Net profitability (%)
0.04 %107.55 % *
Equity (€)
716,069 €0 % *
Amounts Payable And Liabilities (€)
1,752,848 €-7 % *
Non-current Assets (€)
437,667 €90 % *
CurrentAssets (€)
2,150,173 €-16 % *
